← Open Payments lookup

LUCA PAUSELLI: Open Payments

NPI 1811457591 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$897 in 63 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $897

Food & beverage: $897
CompanyPaymentsAmount
ABBVIE INC.36$337
Gilead Sciences, Inc.1$86
Otsuka America Pharmaceutical, Inc.4$73
Alkermes, Inc.4$67
Neurocrine BioSciences, Inc.3$60
Janssen Pharmaceuticals, Inc3$57
E.R. Squibb & Sons, L.L.C.3$52
Supernus Pharmaceuticals, Inc.3$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Teva Pharmaceuticals USA, Inc.2$36

Products named: VRAYLAR, Yeztugo, REXULTI, ARISTADA, INGREZZA, COBENFY, Qelbree, CAPLYTA.

Industry payments across NY — which companies pay providers there.